Otologic Pharmaceutics
How we got $423K
Based on typical figures for its industry (2022 Economic Census), not its own records.
What we know
What they do
Otologic Pharmaceutics, Inc. is a company developing treatments for acute and chronic hearing loss to reduce the incidence and severity of permanent hearing disorders.
From the company's website. Industry: Administrative and support and waste management and remediation services.
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| Otologic Pharmaceutics this business | $1.3M | — |
| Synereca Pharmaceuticals Oklahoma City | $1.3M | 0.0 mi |
| Ou Health Science Center Oklahoma City | $1.3M | 0.0 mi |
| Viewsolid Biotech Inc. Oklahoma City | $1.3M | 0.1 mi |
| Medencentive Oklahoma City | $1.3M | 0.1 mi |
| Polyskope Labs Oklahoma City | $1.3M | 0.1 mi |
| Heparinex L.l.c. Oklahoma City | $1.3M | 0.1 mi |
The full calculation
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.
| Estimated value = EBITDA × typical sale multiple | $423K |
| Multiple for this size and industry | 2.5× |
| Value range | $105K – $755K |
This business has no PPP loan on record, so there is no business-specific data. The figures are the typical estimated revenue of Administrative and support and waste management and remediation services businesses in our Oklahoma data: the middle value, with the range covering the middle half of those businesses. EBITDA applies the industry margin (14%). Treat these as a rough guide.
| Revenue range | $389K – $1.9M |
| EBITDA range | $53K – $252K |
| Industry (NAICS) | Administrative and support and waste management and remediation services (56) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from Overture Maps open data. Full methodology
Public records
Matched to this business by name and address from public government data; a match can occasionally be wrong.
About Otologic Pharmaceutics
Otologic Pharmaceutics is an administrative and support and waste management and remediation services company in Oklahoma City, Oklahoma, in business since 2018. Its estimated annual revenue is about $1.3M, with roughly $169K of EBITDA. Its estimated business value is $423K (likely range $105K–$755K).
Common questions
- Who owns Otologic Pharmaceutics?
- The owner of Otologic Pharmaceutics isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
- How much revenue does Otologic Pharmaceutics make?
- SeeBITDA estimates Otologic Pharmaceutics's annual revenue at about $1.3M (likely between $389K and $1.9M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Otologic Pharmaceutics worth?
- About $423K, roughly 2.5× its estimated EBITDA of $169K, typical for a administrative and support and waste management and remediation services company its size. Likely range: $105K–$755K.
- When was Otologic Pharmaceutics founded?
- Otologic Pharmaceutics has been in business since 2018.